RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 78 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $152,000 | -49.0% | 349,908 | 0.0% | 0.02% | -44.4% |
| Q2 2022 | $298,000 | -84.5% | 349,908 | 0.0% | 0.04% | -87.0% |
| Q1 2022 | $1,928,000 | -43.1% | 349,908 | 0.0% | 0.28% | -22.9% |
| Q4 2021 | $3,387,000 | -74.2% | 349,908 | -86.6% | 0.36% | -99.5% |
| Q3 2020 | $13,118,000 | -16.2% | 2,618,351 | 0.0% | 65.48% | +24.3% |
| Q2 2020 | $15,658,000 | +34.4% | 2,618,351 | 0.0% | 52.68% | +167.8% |
| Q1 2020 | $11,652,000 | -53.2% | 2,618,351 | 0.0% | 19.67% | -39.3% |
| Q4 2019 | $24,874,000 | +21.0% | 2,618,351 | 0.0% | 32.42% | +44.1% |
| Q3 2019 | $20,554,000 | -50.1% | 2,618,351 | 0.0% | 22.50% | -47.2% |
| Q2 2019 | $41,187,000 | -13.1% | 2,618,351 | 0.0% | 42.64% | -6.8% |
| Q1 2019 | $47,392,000 | +12.6% | 2,618,351 | 0.0% | 45.77% | +8.7% |
| Q4 2018 | $42,103,000 | – | 2,618,351 | – | 42.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
| HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
| Artal Group S.A. | 2,042,666 | $357 | 0.02% |
| Virtu Financial LLC | 68,825 | $12 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
| Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
| Citadel Advisors | 600 | $103 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |